instruction stringlengths 732 1.39k | output stringlengths 651 861 |
|---|---|
SUBJECT: Inquiry and feedback about Product A and institutional inquiry
BODY:
To Whom It May Concern,
As the head of pharmacy procurement for a regional health trust and I wish to bring two matters to your attention. The first is a medical information request about Product A specifically Does Product A require premedi... | {"Classification_of_request": {"Classification": "Medical Information, Other", "Confidence_percentage": "96%"}, "Analysis": "The email contains a Medical Information request regarding Product A where the sender seeks specific clinical or scientific information in the form of Does Product A require premedication with an... |
SUBJECT: Multi-product safety and information request for Product A and supply inquiry
BODY:
Dear Regulatory Affairs,
I am the nurse practitioner in a busy GP practice and I am writing to raise two separate matters. The first is an adverse event involving Product A. The patient is a 68 year old male with congestive he... | {"Classification_of_request": {"Classification": "Adverse Event, Other", "Confidence_percentage": "94%"}, "Analysis": "The email reports adverse symptoms where the patient noticed significant peripheral edema in both lower limbs after 1 week of use temporally associated with Product A initiation, with clinical interven... |
SUBJECT: Integrated feedback regarding Product A and institutional contract enquiry
BODY:
Dear Healthcare Liaison,
I am the ward manager on a busy medical unit and I wish to bring two matters to your attention. The first is a quality assurance issue with Product A 25mg where the foil strip was partially cut at an angl... | {"Classification_of_request": {"Classification": "Product Complaint, Other", "Confidence_percentage": "92%"}, "Analysis": "The email reports a product quality defect in Product A where the foil strip was partially cut at an angle, leaving sharp edges that could injure patients during handling in a specific identified b... |
SUBJECT: Healthcare provider memo on Product A and Product B
BODY:
Dear Safety Team,
As the medical liaison for Northshore Physicians Group, I coordinate care transitions involving Product A for respiratory conditions and Product B for cardiovascular protection. and I wish to bring two issues to your attention. The fi... | {"Classification_of_request": {"Classification": "Medical Information, Adverse Event", "Confidence_percentage": "94%"}, "Analysis": "The email contains a Medical Information request regarding Product A where the sender seeks specific clinical or scientific information in the form of Are there any contraindications for ... |
SUBJECT: Joint product evaluation and safety report for Product A and Product B
BODY:
Dear Patient Safety and Market Access Team,
As the director of pharmacy for a network of community hospitals, I oversee the use of Product A in wound care and Product B in pain management protocols. and I am writing to formally raise... | {"Classification_of_request": {"Classification": "Medical Information, Adverse Event", "Confidence_percentage": "92%"}, "Analysis": "The email contains a Medical Information request regarding Product A where the sender seeks specific clinical or scientific information in the form of Does Product A require renal functio... |
SUBJECT: Comprehensive inquiry on Product A and Product B
BODY:
Dear Quality Officer,
I am the ward manager on a busy medical unit where several inindividuals are currently receiving Product A for infection prophylaxis alongside Product B for gastric protection. and I am contacting you about two separate matters. The ... | {"Classification_of_request": {"Classification": "Medical Information, Product Complaint", "Confidence_percentage": "91%"}, "Analysis": "The email contains a Medical Information request regarding Product A where the sender seeks specific clinical or product information in the form of Can you share data on the bioavaila... |
SUBJECT: Supply and experience review of Product A and supply inquiry
BODY:
Dear Customer Support,
I am the clinical lead pharmacist at a large teaching hospital and I am writing to raise two separate matters. The first is an adverse event involving Product A. The patient is a 42 year old female with gestational diabe... | {"Classification_of_request": {"Classification": "Adverse Event, Other", "Confidence_percentage": "93%"}, "Analysis": "The email reports adverse symptoms where the individual reported visual disturbances including blurred vision and photophobia after 3 doses temporally associated with Product A initiation, with clinica... |
SUBJECT: Integrated feedback regarding Product A and supply inquiry
BODY:
Dear Medical Director,
I am writing as the clinical coordinator for a multi-site renal network and I am writing to raise two separate matters. The first is an adverse event involving Product A. The patient is a 34 year old male previously health... | {"Classification_of_request": {"Classification": "Adverse Event, Other", "Confidence_percentage": "91%"}, "Analysis": "The email reports adverse symptoms where the patient reported visual disturbances including blurred vision and photophobia after 3 doses temporally associated with Product A initiation, with clinical i... |
SUBJECT: Healthcare provider memo on Product A and supply inquiry
BODY:
Dear Healthcare Liaison,
I am the nurse practitioner in a busy GP practice and I am writing to raise two separate matters. The first is an adverse event involving Product A. The patient is a 33 year old female with multiple sclerosis on immunomodu... | {"Classification_of_request": {"Classification": "Adverse Event, Other", "Confidence_percentage": "97%"}, "Analysis": "The email reports adverse symptoms where the patient developed deep-vein thrombosis in the left calf within 2 weeks temporally associated with Product A initiation, with clinical intervention taken, qu... |
SUBJECT: Pricing inquiry and safety signal for Product A and supply inquiry
BODY:
Dear Medical Information Team,
I am the lead clinical pharmacist at a regional oncology unit and I have two distinct issues to address. The first concerns Product A where The patient is a 78 year old female on chronic anticoagulation the... | {"Classification_of_request": {"Classification": "Adverse Event, Other", "Confidence_percentage": "96%"}, "Analysis": "The email reports adverse symptoms where the patient developed acute pancreatitis with epigastric pain and elevated lipase after 7 days temporally associated with Product A initiation, with clinical in... |
SUBJECT: Cross-product clinical and quality note on Product A and Product B
BODY:
Dear Clinical Coordinator,
I am the ward manager on a busy medical unit where several inpatients are currently receiving Product A for infection prophylaxis alongside Product B for gastric protection. and I am writing to formally report ... | {"Classification_of_request": {"Classification": "Medical Information, Product Complaint", "Confidence_percentage": "91%"}, "Analysis": "The email contains a Medical Information request regarding Product A where the sender seeks specific clinical or product information in the form of Could you clarify the pregnancy cat... |
SUBJECT: Packaging defect and dosing question for Product A and Product B
BODY:
Dear Quality Assurance Team,
As the head of pharmacy procurement for a regional health trust, I am responsible for supply agreements covering Product A in haematology and Product B in gastroenterology. and I am writing to report two separa... | {"Classification_of_request": {"Classification": "Adverse Event, Product Complaint", "Confidence_percentage": "95%"}, "Analysis": "The email reports adverse symptoms where the patient noticed dark tarry stools indicating possible gastrointestinal bleeding after 8 days temporally associated with Product A initiation, wi... |
SUBJECT: Urgent concern regarding Product A and institutional inquiry
BODY:
Dear Clinical Coordinator,
I am the prescribing advisor for a mental health trust and I am writing to raise two separate matters. The first is a clinical information request regarding Product A which our medical advisory committee is consideri... | {"Classification_of_request": {"Classification": "Medical Information, Other", "Confidence_percentage": "92%"}, "Analysis": "The email contains a Medical Information request regarding Product A where the sender seeks specific clinical or scientific information in the form of Could you provide the maximum recommended da... |
SUBJECT: Unexpected reaction linked to Product A and supply inquiry
BODY:
Dear Drug Safety and Medical Information,
I am the nurse practitioner in a busy GP practice and I am writing to raise two separate matters. The first is an adverse event involving Product A. The patient is a 32 year old female with antiphospholi... | {"Classification_of_request": {"Classification": "Adverse Event, Other", "Confidence_percentage": "92%"}, "Analysis": "The email reports adverse symptoms where the individual developed bilateral hearing loss and persistent tinnitus after 11 days temporally associated with Product A initiation, with clinical interventio... |
SUBJECT: Safety and quality note on Product A and institutional inquiry
BODY:
Dear Medical Information Team,
I am the pharmacy and therapeutics committee chair at a regional medical centre and I am writing to raise two separate matters. The first is a clinical information request regarding Product A which our medical ... | {"Classification_of_request": {"Classification": "Medical Information, Other", "Confidence_percentage": "96%"}, "Analysis": "The email contains a Medical Information request regarding Product A where the sender seeks specific clinical or scientific information in the form of Can you share data on the bioavailability of... |
SUBJECT: Market access and patient impact of Product A and supply inquiry
BODY:
Dear Adverse Event Reporting Center,
I am the clinical lead at a geriatric medicine service and I wish to bring two matters to your attention. The first is an adverse reaction report concerning Product A where The patient is a 68 year old ... | {"Classification_of_request": {"Classification": "Adverse Event, Other", "Confidence_percentage": "93%"}, "Analysis": "The email reports adverse symptoms where the patient developed angioedema of the lips and tongue within 90 minutes of ingestion temporally associated with Product A initiation, with clinical interventi... |
SUBJECT: Combined quality and clinical report for Product A and institutional contract enquiry
BODY:
Dear Clinical Coordinator,
I am the clinical lead at a geriatric medicine service and I have two distinct issues to address. The first concerns Product A 20mg where our quality team found that a tablet was observed to ... | {"Classification_of_request": {"Classification": "Product Complaint, Other", "Confidence_percentage": "94%"}, "Analysis": "The email reports a product quality defect in Product A where a tablet was observed to be split into 2 unequal fragments inside an intact blister cavity in a specific identified batch with quaranti... |
SUBJECT: Inquiry and feedback about Product A and supply inquiry
BODY:
Dear Patient Safety and Market Access Team,
I am the ward manager on a busy medical unit and I am contacting you regarding two separate topics. The first is a safety report for Product A where The patient is a 57 year old male with sleep apnea and ... | {"Classification_of_request": {"Classification": "Adverse Event, Other", "Confidence_percentage": "94%"}, "Analysis": "The email reports adverse symptoms where the patient showed signs of acute renal dysfunction with rising creatinine after 5 days temporally associated with Product A initiation, with clinical intervent... |
SUBJECT: Clarification sought on Product A and supply inquiry
BODY:
Dear Pharmacovigilance and Quality Officer,
I am the chief pharmacist at a district general hospital and I am contacting you regarding two separate topics. The first is a safety report for Product A where The patient is a 73 year old male with Parkins... | {"Classification_of_request": {"Classification": "Adverse Event, Other", "Confidence_percentage": "94%"}, "Analysis": "The email reports adverse symptoms where the patient had an episode of syncope approximately 6 hours post-dose temporally associated with Product A initiation, with clinical intervention taken, qualify... |
SUBJECT: Patient feedback concerning Product A and institutional contract enquiry
BODY:
Dear Patient Safety and Market Access Team,
I am the chief pharmacist at a district general hospital and I am writing to formally raise two separate matters. The first is a product quality concern identified during routine dispensi... | {"Classification_of_request": {"Classification": "Product Complaint, Other", "Confidence_percentage": "94%"}, "Analysis": "The email reports a product quality defect in Product A where the batch number on the vial label did not match the corresponding entry in the electronic pedigree system in a specific identified bat... |
SUBJECT: Clarification sought on Product A and Product B
BODY:
Dear Clinical Affairs,
I am the chief pharmacist at a district general hospital where Product A is stocked in critical care and Product B is used in the renal unit. and I am writing to formally raise two matters. The first concerns Product A and specifical... | {"Classification_of_request": {"Classification": "Medical Information, Adverse Event", "Confidence_percentage": "96%"}, "Analysis": "The email contains a Medical Information request regarding Product A where the sender seeks specific clinical or scientific information in the form of Are there any dietary restrictions o... |
SUBJECT: Clarification sought on Product A and supply inquiry
BODY:
Dear Clinical Affairs,
I am the lead clinical pharmacist at a regional oncology unit and I wish to bring two matters to your attention. The first is an adverse reaction report probleming Product A where The patient is a 28 year old female, 8 weeks pos... | {"Classification_of_request": {"Classification": "Adverse Event, Other", "Confidence_percentage": "95%"}, "Analysis": "The email reports adverse symptoms where the individual experienced a sharp drop in platelet count observed on day 7 lab work temporally associated with Product A initiation, with clinical intervention... |
SUBJECT: Clinical observation with Product A and Product B
BODY:
Dear Product Team,
I am the quality officer at a private hospital where Product A is administered in the infusion centre and Product B is dispensed from the outsubject pharmacy. and I am contacting you about two separate matters. The first is a request f... | {"Classification_of_request": {"Classification": "Medical Information, Product Complaint", "Confidence_percentage": "93%"}, "Analysis": "The email contains a Medical Information request regarding Product A where the sender seeks specific clinical or product information in the form of Does Product A require premedicatio... |
SUBJECT: Clinical observation with Product A and Product B
BODY:
Dear Medical Affairs,
I am the chief pharmacist at a district general hospital where Product A is stocked in critical care and Product B is used in the renal unit. I have two separate matters to raise. Firstly regarding Product A I would like to understa... | {"Classification_of_request": {"Classification": "Medical Information, Adverse Event", "Confidence_percentage": "92%"}, "Analysis": "The email contains a Medical Information request regarding Product A where the sender seeks specific clinical or scientific information in the form of Is there any real-world evidence on ... |
SUBJECT: Combined quality and clinical report for Product A and institutional inquiry
BODY:
Dear Pharmacovigilance and Quality Officer,
I am the clinical pharmacist for a long-term care facility and I am writing to formally request information on two fronts. The first is clinical information regarding Product A where ... | {"Classification_of_request": {"Classification": "Medical Information, Other", "Confidence_percentage": "95%"}, "Analysis": "The email contains a Medical Information request regarding Product A where the sender seeks specific clinical or scientific information in the form of Can you provide the pharmacokinetic profile ... |
SUBJECT: Follow-up needed for Product A and supply inquiry
BODY:
Dear Drug Safety and Medical Information,
I am the clinical pharmacy specialist in a busy emergency department and I am writing to formally report two issues. The first is a individual safety concern with Product A where The patient is a 55 year old fema... | {"Classification_of_request": {"Classification": "Adverse Event, Other", "Confidence_percentage": "91%"}, "Analysis": "The email reports adverse symptoms where the patient complained of severe abdominal cramping and diarrhea for 3 consecutive days temporally associated with Product A initiation, with clinical intervent... |
SUBJECT: Distribution and side-effect profile of Product A and Product B
BODY:
Dear Quality and Commercial Teams,
I am the nurse practitioner in a busy GP practice where we commonly co-prescribe Product A for depression and Product B for anxiety disorders. and I wish to raise two issues. The first concerns medical inf... | {"Classification_of_request": {"Classification": "Medical Information, Product Complaint", "Confidence_percentage": "95%"}, "Analysis": "The email contains a Medical Information request regarding Product A where the sender seeks specific clinical or product information in the form of Could you clarify the pregnancy cat... |
SUBJECT: Multi-faceted concern about Product A and institutional inquiry
BODY:
Dear Medical Affairs,
I am the quality officer at a private hospital and I have two distinct issues to address. Regarding Product A for formulary evaluation, What is the mechanism of action for Product A at the receptor level? Turning to th... | {"Classification_of_request": {"Classification": "Medical Information, Other", "Confidence_percentage": "92%"}, "Analysis": "The email contains a Medical Information request regarding Product A where the sender seeks specific clinical or scientific information in the form of What is the mechanism of action for Product ... |
SUBJECT: Multi-product safety and information request for Product A and Product B
BODY:
Dear Compliance Team,
As the pharmacy director of a 500-bed tertiary hospital, I am coordinating formulary reviews for Product A in cardiology and Product B in neurology. and I wish to raise two issues. The first concerns medical i... | {"Classification_of_request": {"Classification": "Medical Information, Product Complaint", "Confidence_percentage": "96%"}, "Analysis": "The email contains a Medical Information request regarding Product A where the sender seeks specific clinical or product information in the form of Please provide the recommended stor... |
SUBJECT: Issue reported with Product A and institutional contract enquiry
BODY:
Dear Customer Support,
I am the clinical lead pharmacist at a large teaching hospital and I wish to bring two matters to your attention. The first is a quality assurance concern with Product A 20mg where a tablet was observed to be split i... | {"Classification_of_request": {"Classification": "Product Complaint, Other", "Confidence_percentage": "93%"}, "Analysis": "The email reports a product quality defect in Product A where a tablet was found to be split into 2 unequal fragments inside an intact blister cavity in a specific identified batch with quarantined... |
SUBJECT: Patient feedback concerning Product A and Product B
BODY:
Dear Quality Assurance and Commercial Teams,
I am the chief pharmacist at a district general hospital where Product A is stocked in critical care and Product B is used in the renal unit. and I am formally reporting two concerns. The first is a safety i... | {"Classification_of_request": {"Classification": "Adverse Event, Product Complaint", "Confidence_percentage": "97%"}, "Analysis": "The email reports adverse symptoms where the patient developed angioedema of the lips and tongue within 90 minutes of ingestion temporally associated with Product A initiation, with clinica... |
SUBJECT: Observation during use of Product A and Product B
BODY:
Dear Medical Director,
I am the ward manager on a busy medical unit where several inpatients are currently receiving Product A for infection prophylaxis alongside Product B for gastric protection. I have two separate concerns to raise. The first is a cli... | {"Classification_of_request": {"Classification": "Medical Information, Product Complaint", "Confidence_percentage": "97%"}, "Analysis": "The email contains a Medical Information request regarding Product A where the sender seeks specific clinical or product information in the form of Can you share data on the bioavaila... |
SUBJECT: Product quality and adverse experience with Product A and institutional inquiry
BODY:
Dear Quality Assurance and Commercial Teams,
I am writing as the clinical coordinator for a multi-site renal network and I am contacting you regarding two separate topics. The first concerns clinical guidance on Product A wh... | {"Classification_of_request": {"Classification": "Medical Information, Other", "Confidence_percentage": "93%"}, "Analysis": "The email contains a Medical Information request regarding Product A where the sender seeks specific clinical or scientific information in the form of Is Product A approved for pediatric use, and... |
SUBJECT: Safety and quality note on Product A and institutional contract enquiry
BODY:
To Whom It May Concern,
I am the lead clinical coordinator for a hospice network and I am writing to formally report two issues. The first is a product complaint regarding Product A where our inspection revealed that the inhaler can... | {"Classification_of_request": {"Classification": "Product Complaint, Other", "Confidence_percentage": "95%"}, "Analysis": "The email reports a product quality defect in Product A where the inhaler canister appeared dented and the counter mechanism was frozen at 0 doses remaining in a specific identified batch with quar... |
SUBJECT: Combined quality and clinical report for Product A and Product B
BODY:
Dear Pharmacy Director,
I am the ward manager on a busy medical unit where several inpatients are currently receiving Product A for infection prophylaxis alongside Product B for gastric protection. and I wish to bring two issues to your at... | {"Classification_of_request": {"Classification": "Medical Information, Adverse Event", "Confidence_percentage": "96%"}, "Analysis": "The email contains a Medical Information request regarding Product A where the sender seeks specific clinical or scientific information in the form of What is the recommended starting dos... |
SUBJECT: Multi-faceted concern about Product A and Product B
BODY:
Dear Quality Assurance Team,
I am the chief of medicine at a downtown clinic where Product A is prescribed for autoimmune conditions and Product B for metabolic syndrome management. and I need to address two separate issues. Regarding Product A our cli... | {"Classification_of_request": {"Classification": "Medical Information, Adverse Event", "Confidence_percentage": "94%"}, "Analysis": "The email contains a Medical Information request regarding Product A where the sender seeks specific clinical or scientific information in the form of Can you share the patient-reported o... |
SUBJECT: Safety and quality note on Product A and Product B
BODY:
Dear Post-Market Surveillance,
I am the ward manager on a busy medical unit where several inpatients are currently receiving Product A for infection prophylaxis alongside Product B for gastric protection. and I wish to raise two issues simultaneously. T... | {"Classification_of_request": {"Classification": "Adverse Event, Product Complaint", "Confidence_percentage": "92%"}, "Analysis": "The email reports adverse symptoms where the patient noticed dark tarry stools indicating possible gastrointestinal bleeding after 8 days temporally associated with Product A initiation, wi... |
SUBJECT: Urgent matter regarding Product A and Product B
BODY:
Dear Medical and Commercial Teams,
Our outpatient clinic manages a cohort of patients on Product A for anticoagulation and Product B for pain management after orthopaedic surgery. I have two separate matters to raise. Firstly regarding Product A I would li... | {"Classification_of_request": {"Classification": "Medical Information, Adverse Event", "Confidence_percentage": "96%"}, "Analysis": "The email contains a Medical Information request regarding Product A where the sender seeks specific clinical or scientific information in the form of Can you share data on the bioavailab... |
SUBJECT: Observation during use of Product A and institutional inquiry
BODY:
Dear Patient Support,
As the formulary coordinator for a 300-bed community hospital and I am contacting you regarding two separate topics. The first concerns clinical guidance on Product A where What are the documented drug-drug interactions ... | {"Classification_of_request": {"Classification": "Medical Information, Other", "Confidence_percentage": "95%"}, "Analysis": "The email contains a Medical Information request regarding Product A where the sender seeks specific clinical or scientific information in the form of What are the documented drug-drug interactio... |
SUBJECT: Patient feedback issueing Product A and Product B
BODY:
Dear Regulatory Affairs,
As the formulary coordinator for a 300-bed community hospital, I manage requests for Product A in the respiratory clinic and Product B in the rheumatology service. and I am formally reporting two concerns. The first is a safety i... | {"Classification_of_request": {"Classification": "Adverse Event, Product Complaint", "Confidence_percentage": "92%"}, "Analysis": "The email reports adverse symptoms where the patient had uncontrolled tremors in both hands beginning the second day temporally associated with Product A initiation, with clinical intervent... |
SUBJECT: Multi-faceted concern about Product A and Product B
BODY:
Dear Medical and Commercial Teams,
As the medical liaison for Northshore Physicians Group, I coordinate care transitions involving Product A for respiratory conditions and Product B for cardiovascular protection. and I am writing to raise two distinct ... | {"Classification_of_request": {"Classification": "Medical Information, Adverse Event", "Confidence_percentage": "91%"}, "Analysis": "The email contains a Medical Information request regarding Product A where the sender seeks specific clinical or scientific information in the form of Could you provide the maximum recomm... |
SUBJECT: Distribution and side-effect profile of Product A and supply inquiry
BODY:
Dear Clinical Coordinator,
I am the quality officer at a private hospital and I wish to bring two matters to your attention. The first is an adverse reaction report issueing Product A where The patient is a 26 year old female with epil... | {"Classification_of_request": {"Classification": "Adverse Event, Other", "Confidence_percentage": "98%"}, "Analysis": "The email reports adverse symptoms where the patient developed a widespread erythematous rash within 48 hours of the first dose temporally associated with Product A initiation, with clinical interventi... |
SUBJECT: Comprehensive inquiry on Product A and institutional inquiry
BODY:
Dear Adverse Event Reporting Center,
I am the clinical pharmacist for a long-term care facility and I am contacting you regarding two separate topics. The first concerns clinical guidance on Product A where Can you confirm the shelf life and b... | {"Classification_of_request": {"Classification": "Medical Information, Other", "Confidence_percentage": "96%"}, "Analysis": "The email contains a Medical Information request regarding Product A where the sender seeks specific clinical or scientific information in the form of Can you confirm the shelf life and beyond-us... |
SUBJECT: Multi-product safety and information request for Product A and supply inquiry
BODY:
Dear Pharmacovigilance Team,
As the head of pharmacy procurement for a regional health trust and I am writing to formally report two issues. The first is a patient safety concern with Product A where The patient is a 38 year o... | {"Classification_of_request": {"Classification": "Adverse Event, Other", "Confidence_percentage": "92%"}, "Analysis": "The email reports adverse symptoms where the patient developed acute pancreatitis with epigastric pain and elevated lipase after 7 days temporally associated with Product A initiation, with clinical in... |
SUBJECT: Complex issue involving Product A and supply inquiry
BODY:
Dear Healthcare Liaison,
I am the nurse practitioner in a busy GP practice and I am writing to raise two separate matters. The first is an adverse event involving Product A. The patient is a 63 year old female with osteoporosis. She was started on Pro... | {"Classification_of_request": {"Classification": "Adverse Event, Other", "Confidence_percentage": "97%"}, "Analysis": "The email reports adverse symptoms where the patient developed severe photosensitivity with blistering after 14 days of continuous use temporally associated with Product A initiation, with clinical int... |
SUBJECT: Patient feedback concerning Product A and institutional contract enquiry
BODY:
Dear Adverse Event Reporting Center,
I am the clinical pharmacy specialist in a busy emergency department and I have two distinct issues to address. The first concerns Product A 50mg where our quality team found that the outer box ... | {"Classification_of_request": {"Classification": "Product Complaint, Other", "Confidence_percentage": "92%"}, "Analysis": "The email reports a product quality defect in Product A where the outer box was water-damaged during transit, affecting the legibility of dosage instructions printed on the flap in a specific ident... |
SUBJECT: Supply and experience review of Product A and supply inquiry
BODY:
Dear Customer Support,
As the pharmacy director of a 500-bed tertiary hospital and I am writing to raise two separate matters. The first is an adverse event involving Product A. The patient is a 54 year old male with type 1 diabetes and periph... | {"Classification_of_request": {"Classification": "Adverse Event, Other", "Confidence_percentage": "91%"}, "Analysis": "The email reports adverse symptoms where the patient developed deep-vein thrombosis in the left calf within 2 weeks temporally associated with Product A initiation, with clinical intervention taken, qu... |
SUBJECT: Healthcare provider memo on Product A and institutional contract enquiry
BODY:
Dear Compliance Team,
I am the lead clinical pharmacist at a regional oncology unit and I am writing to formally report two issues. The first is a product complaint regarding Product A where our inspection revealed that the adhesiv... | {"Classification_of_request": {"Classification": "Product Complaint, Other", "Confidence_percentage": "98%"}, "Analysis": "The email reports a product quality defect in Product A where the adhesive on the secondary label failed, causing it to detach from the primary container surface in a specific identified batch with... |
SUBJECT: Joint product evaluation and safety report for Product A and institutional contract enquiry
BODY:
Dear Drug Safety and Medical Information,
I am the clinical lead pharmacist at a large teaching hospital and I wish to bring two matters to your attention. The first is a quality assurance concern with Product A ... | {"Classification_of_request": {"Classification": "Product Complaint, Other", "Confidence_percentage": "95%"}, "Analysis": "The email reports a product quality defect in Product A where a vial arrived with a cracked neck, causing leakage of approximately 2 ml of solution in a specific identified batch with quarantined s... |
SUBJECT: Clarification sought on Product A and supply inquiry
BODY:
Dear Pharmacovigilance and Quality Officer,
As the pharmacy director of a 500-bed tertiary hospital and I wish to bring two matters to your attention. The first is an adverse reaction report concerning Product A where The patient is a 55 year old fema... | {"Classification_of_request": {"Classification": "Adverse Event, Other", "Confidence_percentage": "97%"}, "Analysis": "The email reports adverse symptoms where the patient developed severe photosensitivity with blistering after 14 days of continuous use temporally associated with Product A initiation, with clinical int... |
SUBJECT: Healthcare provider memo on Product A and Product B
BODY:
Dear Clinical and Supply Chain Team,
As the institutional buyer for City Hospital Network, I am responsible for inventory planning that includes Product A for emergency resuscitation and Product B for chronic disease management. I have two separate mat... | {"Classification_of_request": {"Classification": "Medical Information, Adverse Event", "Confidence_percentage": "91%"}, "Analysis": "The email contains a Medical Information request regarding Product A where the sender seeks specific clinical or scientific information in the form of What is the mechanism of action for ... |
SUBJECT: Dual product inquiry and report about Product A and institutional contract enquiry
BODY:
Dear Quality Assurance Team,
I am the pharmacy and therapeutics committee chair at a regional medical centre and I wish to bring two matters to your attention. The first is a quality assurance concern with Product A 50mg ... | {"Classification_of_request": {"Classification": "Product Complaint, Other", "Confidence_percentage": "96%"}, "Analysis": "The email reports a product quality defect in Product A where the prefilled pen device emitted an audible click but did not deliver the full dose when activated in a specific identified batch with ... |
SUBJECT: Labeling error and clinical query about Product A and institutional inquiry
BODY:
Dear Clinical and Supply Chain Team,
As the pharmacy director of a 500-bed tertiary hospital and I am writing to raise two separate matters. The first is a clinical information request regarding Product A which our medical advis... | {"Classification_of_request": {"Classification": "Medical Information, Other", "Confidence_percentage": "94%"}, "Analysis": "The email contains a Medical Information request regarding Product A where the sender seeks specific clinical or scientific information in the form of Are there any contraindications for Product ... |
SUBJECT: Observation during use of Product A and institutional contract enquiry
BODY:
Dear Compliance Team,
I am the clinical lead pharmacist at a large teaching hospital and I wish to bring two matters to your attention. The first is a quality assurance concern with Product A 20mg where the oral syringe provided in t... | {"Classification_of_request": {"Classification": "Product Complaint, Other", "Confidence_percentage": "97%"}, "Analysis": "The email reports a product quality defect in Product A where the oral syringe provided in the kit had illegible graduation markings making accurate dosing impossible in a specific identified batch... |
SUBJECT: Supply and experience review of Product A and institutional inquiry
BODY:
Dear Quality Assurance Team,
I am the clinical pharmacy specialist in a busy emergency department and I have two distinct issues to address. Regarding Product A for formulary evaluation, Please provide the immunogenicity risk assessment... | {"Classification_of_request": {"Classification": "Medical Information, Other", "Confidence_percentage": "98%"}, "Analysis": "The email contains a Medical Information request regarding Product A where the sender seeks specific clinical or scientific information in the form of Please provide the immunogenicity risk asses... |
SUBJECT: Request for details about Product A and institutional contract enquiry
BODY:
Dear Pharmacovigilance Team,
I am the medical director of a residential care home group managing over 400 elderly residents and I am contacting you regarding two separate topics. The first is a product defect report for Product A whe... | {"Classification_of_request": {"Classification": "Product Complaint, Other", "Confidence_percentage": "96%"}, "Analysis": "The email reports a product quality defect in Product A where the label on the outer carton displayed an incorrect batch number compared to the inner foil strip in a specific identified batch with ... |
SUBJECT: Urgent concern regarding Product A and Product B
BODY:
Dear Compliance Team,
I am the chief of medicine at a downtown clinic where Product A is prescribed for autoimmune conditions and Product B for metabolic syndrome management. and I am writing to formally raise two matters. The first concerns Product A and... | {"Classification_of_request": {"Classification": "Medical Information, Adverse Event", "Confidence_percentage": "98%"}, "Analysis": "The email contains a Medical Information request regarding Product A where the sender seeks specific clinical or scientific information in the form of Can you confirm the shelf life and b... |
SUBJECT: Unexpected reaction linked to Product A and supply inquiry
BODY:
Dear Regulatory Affairs,
I am the clinical pharmacist for a long-term care facility and I wish to bring two matters to your attention. The first is an adverse reaction report mattering Product A where The patient is a 58 year old male with COPD.... | {"Classification_of_request": {"Classification": "Adverse Event, Other", "Confidence_percentage": "98%"}, "Analysis": "The email reports adverse symptoms where the patient developed angioedema of the lips and tongue within 90 minutes of ingestion temporally associated with Product A initiation, with clinical interventi... |
SUBJECT: Distribution and side-effect profile of Product A and supply inquiry
BODY:
Dear Customer Support,
I am the director of pharmacy for a network of community hospitals and I am writing to raise two separate matters. The first is an adverse event involving Product A. The patient is a 28 year old female, 8 weeks p... | {"Classification_of_request": {"Classification": "Adverse Event, Other", "Confidence_percentage": "94%"}, "Analysis": "The email reports adverse symptoms where the individual experienced hypoglycemic episodes requiring emergency glucose administration temporally associated with Product A initiation, with clinical inter... |
SUBJECT: Inquiry and feedback about Product A and institutional inquiry
BODY:
Dear Quality Assurance and Commercial Teams,
I am the lead clinical pharmacist at a regional oncology unit and I wish to bring two matters to your attention. The first is a medical information request about Product A specifically Can you cla... | {"Classification_of_request": {"Classification": "Medical Information, Other", "Confidence_percentage": "98%"}, "Analysis": "The email contains a Medical Information request regarding Product A where the sender seeks specific clinical or scientific information in the form of Can you clarify whether Product A is indicat... |
SUBJECT: Product quality and adverse experience with Product A and Product B
BODY:
To Whom It May Concern,
I am the healthcare administrator at Premier Medical Group overseeing the concurrent use of Product A in infusion centres and Product B in outpatient pharmacies. and I am writing to formally report two distinct m... | {"Classification_of_request": {"Classification": "Medical Information, Product Complaint", "Confidence_percentage": "95%"}, "Analysis": "The email contains a Medical Information request regarding Product A where the sender seeks specific clinical or product information in the form of Is there a black box warning or reg... |
SUBJECT: Product quality and adverse experience with Product A and Product B
BODY:
Dear Medical Information and Safety Team,
I am the senior consultant at Global Health Partners advising on the combined formulary placement of Product A for oncology supportive care and Product B for nutritional supplementation. and I a... | {"Classification_of_request": {"Classification": "Medical Information, Product Complaint", "Confidence_percentage": "93%"}, "Analysis": "The email contains a Medical Information request regarding Product A where the sender seeks specific clinical or product information in the form of Is there a black box warning or reg... |
SUBJECT: Supply and experience review of Product A and Product B
BODY:
Dear Product Team,
I am the lead clinical coordinator for a hospice network where Product A is used for chronic pain and Product B for breakthrough symptom control. I have two distinct concerns to raise. The first is an adverse reaction my patient ... | {"Classification_of_request": {"Classification": "Adverse Event, Product Complaint", "Confidence_percentage": "95%"}, "Analysis": "The email reports adverse symptoms where the subject noticed significant peripheral edema in both lower limbs after 1 week of use temporally associated with Product A initiation, with clini... |
SUBJECT: Administrative and medical query on Product A and Product B
BODY:
Dear Product Team,
I am the clinical lead pharmacist at a large teaching hospital where Product A is used in the oncology unit and Product B is used in the endocrinology service. and I am writing to formally report two distinct matters. Regardi... | {"Classification_of_request": {"Classification": "Medical Information, Product Complaint", "Confidence_percentage": "95%"}, "Analysis": "The email contains a Medical Information request regarding Product A where the sender seeks specific clinical or product information in the form of What is the established dosing inte... |
SUBJECT: Unexpected reaction linked to Product A and institutional inquiry
BODY:
To Whom It May Concern,
I am the director of pharmacy for a network of community hospitals and I am writing to formally request information on two fronts. The first is clinical information regarding Product A where Can you provide the pha... | {"Classification_of_request": {"Classification": "Medical Information, Other", "Confidence_percentage": "97%"}, "Analysis": "The email contains a Medical Information request regarding Product A where the sender seeks specific clinical or scientific information in the form of Can you provide the pharmacokinetic profile ... |
SUBJECT: Supply and experience review of Product A and supply inquiry
BODY:
Dear Clinical and Supply Chain Team,
I am the prescribing advisor for a mental health trust and I am contacting you regarding two separate topics. The first is a safety report for Product A where The patient is a 52 year old male with hepatiti... | {"Classification_of_request": {"Classification": "Adverse Event, Other", "Confidence_percentage": "94%"}, "Analysis": "The email reports adverse symptoms where the patient observed blood in urine after 4 days of administration temporally associated with Product A initiation, with clinical intervention taken, qualifying... |
SUBJECT: Dual product inquiry and report about Product A and Product B
BODY:
Dear Adverse Event Reporting Center,
Our hospital pharmacist network reviews dual-product regimens including Product A for infectious disease and Product B for prophylactic gastroprotection. and I wish to bring two issues to your attention. T... | {"Classification_of_request": {"Classification": "Medical Information, Adverse Event", "Confidence_percentage": "94%"}, "Analysis": "The email contains a Medical Information request regarding Product A where the sender seeks specific clinical or scientific information in the form of Does Product A require renal functio... |
SUBJECT: Issue reported with Product A and Product B
BODY:
Dear Medical and Commercial Teams,
I am the pharmacy and therapeutics committee chair at a regional medical centre evaluating co-administration protocols for Product A and Product B in high-risk populations. and I need to address two separate issues. Regarding... | {"Classification_of_request": {"Classification": "Medical Information, Adverse Event", "Confidence_percentage": "94%"}, "Analysis": "The email contains a Medical Information request regarding Product A where the sender seeks specific clinical or scientific information in the form of Are there any dietary restrictions o... |
SUBJECT: Supply and experience review of Product A and supply inquiry
BODY:
Dear Clinical Lead Pharmacist,
As the head of pharmacy procurement for a regional health trust and I am writing to formally report two issues. The first is a patient safety concern with Product A where The patient is a 67 year old female with ... | {"Classification_of_request": {"Classification": "Adverse Event, Other", "Confidence_percentage": "94%"}, "Analysis": "The email reports adverse symptoms where the patient developed acute pancreatitis with epigastric pain and elevated lipase after 7 days temporally associated with Product A initiation, with clinical in... |
SUBJECT: Clarification sought on Product A and supply inquiry
BODY:
Dear Quality Assurance Team,
I am the clinical lead at a geriatric medicine service and I have two distinct issues to address. The first concerns Product A where The patient is a 32 year old female with antiphospholipid syndrome and recurrent miscarri... | {"Classification_of_request": {"Classification": "Adverse Event, Other", "Confidence_percentage": "91%"}, "Analysis": "The email reports adverse symptoms where the patient reported dyspnea and chest tightness within 30 minutes of ingestion temporally associated with Product A initiation, with clinical intervention take... |
SUBJECT: Administrative and medical query on Product A and Product B
BODY:
Dear Clinical Lead Pharmacist,
Our integrated care system manages patients discharged on Product A for heart failure and Product B for chronic pain across 15 community clinics. and I am contacting you about two separate matters. The first is a ... | {"Classification_of_request": {"Classification": "Medical Information, Product Complaint", "Confidence_percentage": "93%"}, "Analysis": "The email contains a Medical Information request regarding Product A where the sender seeks specific clinical or product information in the form of Please provide the immunogenicity r... |
SUBJECT: Market access and patient impact of Product A and Product B
BODY:
Dear Medical Information Team,
As the procurement lead for Alpha Hospital Consortium, I manage tenders that include Product A for critical care sedation and Product B for peri-operative analgesia. and I need to bring two matters to your attenti... | {"Classification_of_request": {"Classification": "Adverse Event, Product Complaint", "Confidence_percentage": "93%"}, "Analysis": "The email reports adverse symptoms where the patient developed a widespread erythematous rash within 48 hours of the first dose temporally associated with Product A initiation, with clinica... |
SUBJECT: Observation during use of Product A and Product B
BODY:
Dear Quality Assurance and Commercial Teams,
I am the prescribing advisor for a mental health trust where Product A is used for bipolar disorder and Product B for sleep disturbances. and I need to bring two matters to your attention. Regarding Product A ... | {"Classification_of_request": {"Classification": "Adverse Event, Product Complaint", "Confidence_percentage": "92%"}, "Analysis": "The email reports adverse symptoms where the individual reported severe muscle pain with elevated creatine kinase levels on day 9 temporally associated with Product A initiation, with clini... |
SUBJECT: Distribution and side-effect profile of Product A and institutional contract enquiry
BODY:
Dear Clinical and Supply Chain Team,
I am the nurse practitioner in a busy GP practice and I have two distinct issues to address. The first concerns Product A 20mg where our quality team found that the batch number on t... | {"Classification_of_request": {"Classification": "Product Complaint, Other", "Confidence_percentage": "98%"}, "Analysis": "The email reports a product quality defect in Product A where the batch number on the vial label did not match the corresponding entry in the electronic pedigree system in a specific identified bat... |
SUBJECT: Safety and quality note on Product A and supply inquiry
BODY:
Dear Customer Support,
I am the clinical pharmacist for a long-term care facility and I wish to bring two matters to your attention. The first is an adverse reaction report concerning Product A where The patient is a 82 year old female with osteoar... | {"Classification_of_request": {"Classification": "Adverse Event, Other", "Confidence_percentage": "97%"}, "Analysis": "The email reports adverse symptoms where the patient noticed yellowing of sclera and skin suggestive of hepatic involvement after 10 days temporally associated with Product A initiation, with clinical ... |
SUBJECT: Observation during use of Product A and supply inquiry
BODY:
Dear Drug Safety Department,
I am the clinical pharmacist for a long-term care facility and I am writing to formally report two issues. The first is a patient safety concern with Product A where The patient is a 28 year old female, 8 weeks postpartu... | {"Classification_of_request": {"Classification": "Adverse Event, Other", "Confidence_percentage": "95%"}, "Analysis": "The email reports adverse symptoms where the patient developed a widespread erythematous rash within 48 hours of the first dose temporally associated with Product A initiation, with clinical interventi... |
SUBJECT: Pricing inquiry and safety signal for Product A and supply inquiry
BODY:
To Whom It May Concern,
I am the director of pharmacy for a network of community hospitals and I wish to bring two matters to your attention. The first is an adverse reaction report concerning Product A where The patient is a 60 year old... | {"Classification_of_request": {"Classification": "Adverse Event, Other", "Confidence_percentage": "91%"}, "Analysis": "The email reports adverse symptoms where the patient suffered hypoglycemic episodes requiring emergency glucose administration temporally associated with Product A initiation, with clinical interventio... |
SUBJECT: Clarification sought on Product A and Product B
BODY:
Dear Customer Support,
As the formulary coordinator for a 300-bed community hospital, I manage requests for Product A in the respiratory clinic and Product B in the rheumatology service. and I wish to raise two issues simultaneously. The first is an advers... | {"Classification_of_request": {"Classification": "Adverse Event, Product Complaint", "Confidence_percentage": "94%"}, "Analysis": "The email reports adverse symptoms where the patient experienced acute chest pain radiating to the left arm within 4 hours of the dose temporally associated with Product A initiation, with ... |
SUBJECT: Issue reported with Product A and supply inquiry
BODY:
Dear Medical Affairs,
I am the head of formulary and medicines optimisation for an integrated care board and I wish to bring two matters to your attention. The first is an adverse reaction report concerning Product A where The patient is a 28 year old fem... | {"Classification_of_request": {"Classification": "Adverse Event, Other", "Confidence_percentage": "97%"}, "Analysis": "The email reports adverse symptoms where the patient experienced profound fatigue and muscle weakness after 6 days of treatment temporally associated with Product A initiation, with clinical interventi... |
SUBJECT: Multi-product safety and information request for Product A and Product B
BODY:
Dear Medical Affairs,
I am the chief of medicine at a downtown clinic where Product A is prescribed for autoimmune conditions and Product B for metabolic syndrome management. and I am writing to raise two distinct concerns. The fir... | {"Classification_of_request": {"Classification": "Medical Information, Adverse Event", "Confidence_percentage": "92%"}, "Analysis": "The email contains a Medical Information request regarding Product A where the sender seeks specific clinical or scientific information in the form of Can you clarify whether Product A is... |
SUBJECT: Dual product inquiry and report about Product A and institutional contract enquiry
BODY:
Dear Medical Information Team,
I am the clinical pharmacy specialist in a busy emergency department and I am writing to formally raise two separate matters. The first is a product quality concern identified during routine... | {"Classification_of_request": {"Classification": "Product Complaint, Other", "Confidence_percentage": "91%"}, "Analysis": "The email reports a product quality defect in Product A where the barcode on the outer packaging failed to scan at three separate pharmacy workstations in a specific identified batch with quarantin... |
SUBJECT: Clinical observation with Product A and institutional contract enquiry
BODY:
Dear Medical Information and Safety Team,
I am the lead clinical coordinator for a hospice network and I have two distinct issues to address. The first concerns Product A 50mg where our quality team found that the inhaler canister ap... | {"Classification_of_request": {"Classification": "Product Complaint, Other", "Confidence_percentage": "95%"}, "Analysis": "The email reports a product quality defect in Product A where the inhaler canister appeared dented and the counter mechanism was frozen at 0 doses remaining in a specific identified batch with quar... |
SUBJECT: Market access and patient impact of Product A and Product B
BODY:
Dear Drug Safety and Medical Information,
As the institutional buyer for City Hospital Network, I am responsible for inventory planning that includes Product A for emergency resuscitation and Product B for chronic disease management. and I wish... | {"Classification_of_request": {"Classification": "Adverse Event, Product Complaint", "Confidence_percentage": "92%"}, "Analysis": "The email reports adverse symptoms where the patient had uncontrolled tremors in both hands beginning the second day temporally associated with Product A initiation, with clinical intervent... |
SUBJECT: Follow-up needed for Product A and institutional inquiry
BODY:
Dear Quality Assurance Team,
I am the pharmacy and therapeutics committee chair at a regional medical centre and I am contacting you regarding two separate topics. The first concerns clinical guidance on Product A where Can you confirm the shelf l... | {"Classification_of_request": {"Classification": "Medical Information, Other", "Confidence_percentage": "96%"}, "Analysis": "The email contains a Medical Information request regarding Product A where the sender seeks specific clinical or scientific information in the form of Can you confirm the shelf life and beyond-us... |
SUBJECT: Follow-up needed for Product A and Product B
BODY:
Dear Clinical Lead Pharmacist,
As the pharmacy director of a 500-bed tertiary hospital, I am coordinating formulary reviews for Product A in cardiology and Product B in neurology. and I need to address two issues simultaneously. The first is a medical informa... | {"Classification_of_request": {"Classification": "Medical Information, Product Complaint", "Confidence_percentage": "92%"}, "Analysis": "The email contains a Medical Information request regarding Product A where the sender seeks specific clinical or product information in the form of Can you provide the pharmacokinetic... |
SUBJECT: Clinical observation with Product A and institutional inquiry
BODY:
Dear Quality and Commercial Teams,
I am the ward manager on a busy medical unit and I am writing to formally request information on two fronts. The first is clinical information regarding Product A where Can you provide a summary of clinical ... | {"Classification_of_request": {"Classification": "Medical Information, Other", "Confidence_percentage": "95%"}, "Analysis": "The email contains a Medical Information request regarding Product A where the sender seeks specific clinical or scientific information in the form of Can you provide a summary of clinical trials... |
SUBJECT: Labeling error and clinical query about Product A and supply inquiry
BODY:
Dear Patient Safety and Market Access Team,
I am the medical director of a specialist cardiovascular centre and I am writing to formally report two issues. The first is a patient safety concern with Product A where The patient is a 34 ... | {"Classification_of_request": {"Classification": "Adverse Event, Other", "Confidence_percentage": "96%"}, "Analysis": "The email reports adverse symptoms where the patient complained of severe abdominal cramping and diarrhea for 3 consecutive days temporally associated with Product A initiation, with clinical intervent... |
SUBJECT: Healthcare provider memo on Product A and Product B
BODY:
Dear Pharmacy Director,
I am the quality officer at a private hospital where Product A is administered in the infusion centre and Product B is dispensed from the outpatient pharmacy. I have two distinct concerns to raise. The first is an adverse reacti... | {"Classification_of_request": {"Classification": "Adverse Event, Product Complaint", "Confidence_percentage": "94%"}, "Analysis": "The email reports adverse symptoms where the subject had an episode of syncope approximately 6 hours post-dose temporally associated with Product A initiation, with clinical intervention an... |
SUBJECT: Cross-product clinical and quality note on Product A and Product B
BODY:
Dear Quality Assurance Team,
Our supply chain team coordinates direct-to-ward deliveries of Product A for stroke units and Product B for orthopaedic wards across the National Health Trust. and I am writing to raise two distinct concerns.... | {"Classification_of_request": {"Classification": "Medical Information, Adverse Event", "Confidence_percentage": "91%"}, "Analysis": "The email contains a Medical Information request regarding Product A where the sender seeks specific clinical or scientific information in the form of Does Product A require renal functio... |
SUBJECT: Cross-product clinical and quality note on Product A and Product B
BODY:
Dear Quality Assurance Team,
As the pharmacy director of a 500-bed tertiary hospital, I am coordinating formulary reviews for Product A in cardiology and Product B in neurology. and I wish to bring two issues to your attention. The first... | {"Classification_of_request": {"Classification": "Medical Information, Adverse Event", "Confidence_percentage": "97%"}, "Analysis": "The email contains a Medical Information request regarding Product A where the sender seeks specific clinical or scientific information in the form of Could you provide the maximum recomm... |
SUBJECT: Cross-product clinical and quality note on Product A and Product B
BODY:
Dear Patient Safety and Market Access Team,
As the pharmacy director of a 500-bed tertiary hospital, I am coordinating formulary reviews for Product A in cardiology and Product B in neurology. I have two separate matters to raise. Firstl... | {"Classification_of_request": {"Classification": "Medical Information, Adverse Event", "Confidence_percentage": "97%"}, "Analysis": "The email contains a Medical Information request regarding Product A where the sender seeks specific clinical or scientific information in the form of What are the documented drug-drug in... |
SUBJECT: Joint product evaluation and safety report for Product A and Product B
BODY:
Dear Pharmacy Director,
Our supply chain team coordinates direct-to-ward deliveries of Product A for stroke units and Product B for orthopaedic wards across the National Health Trust. and I am writing to formally report two distinct ... | {"Classification_of_request": {"Classification": "Medical Information, Product Complaint", "Confidence_percentage": "94%"}, "Analysis": "The email contains a Medical Information request regarding Product A where the sender seeks specific clinical or product information in the form of Does Product A have any known inter... |
SUBJECT: Comprehensive inquiry on Product A and institutional inquiry
BODY:
Dear Integrated Quality and Safety Team,
I am the clinical pharmacist for a long-term care facility and I am writing to raise two separate matters. The first is a clinical information request regarding Product A which our medical advisory comm... | {"Classification_of_request": {"Classification": "Medical Information, Other", "Confidence_percentage": "95%"}, "Analysis": "The email contains a Medical Information request regarding Product A where the sender seeks specific clinical or scientific information in the form of Are there any dietary restrictions or food i... |
SUBJECT: Dual product inquiry and report about Product A and institutional contract enquiry
BODY:
Dear Patient Support,
As the pharmacy director of a 500-bed tertiary hospital and I am writing to formally raise two separate matters. The first is a product quality concern identified during routine dispensing inspection... | {"Classification_of_request": {"Classification": "Product Complaint, Other", "Confidence_percentage": "92%"}, "Analysis": "The email reports a product quality defect in Product A where the powder for reconstitution formed clumps that did not dissolve completely after 5 minutes of shaking in a specific identified batch ... |
SUBJECT: Multi-faceted concern about Product A and supply inquiry
BODY:
Dear Clinical and Supply Chain Team,
I am the clinical pharmacist for a long-term care facility and I am writing to raise two separate matters. The first is an adverse event involving Product A. The patient is a 70 year old male with aortic stenos... | {"Classification_of_request": {"Classification": "Adverse Event, Other", "Confidence_percentage": "97%"}, "Analysis": "The email reports adverse symptoms where the patient experienced severe nausea and repeated vomiting starting on day 3 of therapy temporally associated with Product A initiation, with clinical interven... |
SUBJECT: Multi-product safety and information request for Product A and institutional inquiry
BODY:
Dear Post-Market Surveillance,
As the formulary coordinator for a 300-bed community hospital and I am writing to raise two separate matters. The first is a clinical information request regarding Product A which our medi... | {"Classification_of_request": {"Classification": "Medical Information, Other", "Confidence_percentage": "96%"}, "Analysis": "The email contains a Medical Information request regarding Product A where the sender seeks specific clinical or scientific information in the form of What adverse reactions are listed in the ref... |
SUBJECT: Comprehensive inquiry on Product A and Product B
BODY:
Dear Product Team,
Our outpatient clinic manages a cohort of patients on Product A for anticoagulation and Product B for pain management after orthopaedic surgery. and I need to bring two matters to your attention. Regarding Product A The patient is a 29 ... | {"Classification_of_request": {"Classification": "Adverse Event, Product Complaint", "Confidence_percentage": "91%"}, "Analysis": "The email reports adverse symptoms where the patient developed Stevens-Johnson syndrome-like lesions across torso and arms temporally associated with Product A initiation, with clinical int... |
SUBJECT: Comprehensive inquiry on Product A and Product B
BODY:
Dear Clinical and Supply Chain Team,
Our outpatient clinic manages a cohort of patients on Product A for anticoagulation and Product B for pain management after orthopaedic surgery. and I wish to raise two issues simultaneously. The first is an adverse ev... | {"Classification_of_request": {"Classification": "Adverse Event, Product Complaint", "Confidence_percentage": "97%"}, "Analysis": "The email reports adverse symptoms where the patient complained of severe abdominal cramping and diarrhea for 3 consecutive days temporally associated with Product A initiation, with clinic... |
SUBJECT: Multi-faceted concern about Product A and Product B
BODY:
Dear Medical Information and Safety Team,
As the head of pharmacy procurement for a regional health trust, I am responsible for supply agreements covering Product A in haematology and Product B in gastroenterology. and I need to bring two matters to yo... | {"Classification_of_request": {"Classification": "Adverse Event, Product Complaint", "Confidence_percentage": "94%"}, "Analysis": "The email reports adverse symptoms where the patient reported visual disturbances including blurred vision and photophobia after 3 doses temporally associated with Product A initiation, wit... |
SUBJECT: Clinical observation with Product A and institutional contract enquiry
BODY:
Dear Integrated Quality and Safety Team,
I am the lead clinical pharmacist at a regional oncology unit and I am writing to formally report two issues. The first is a product complaint regarding Product A where our inspection revealed... | {"Classification_of_request": {"Classification": "Product Complaint, Other", "Confidence_percentage": "91%"}, "Analysis": "The email reports a product quality defect in Product A where the syringe plunger was stuck and could not be depressed smoothly, suggesting a manufacturing defect in a specific identified batch wit... |
Subsets and Splits
No community queries yet
The top public SQL queries from the community will appear here once available.